| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | HSPG2 FBN2 TFPI2 FGA LAMA3 LAMA4 LAMC1 NID1 LTBP1 LTBP2 LTBP4 MUC5AC FBN3 | 5.87e-16 | 188 | 49 | 13 | GO:0005201 |
| GeneOntologyMolecularFunction | calcium ion binding | HSPG2 FAT4 FAT1 STAB2 FBN2 MEGF6 ITGB1BP2 GNPTAB SLIT1 NID1 LTBP1 DLK1 LTBP2 LTBP4 FBN3 NOTCH2 CRB1 | 1.02e-12 | 749 | 49 | 17 | GO:0005509 |
| GeneOntologyMolecularFunction | structural molecule activity | HSPG2 FBN2 TFPI2 FGA LAMA3 LAMA4 LAMC1 NID1 LAMC3 LTBP1 LTBP2 LTBP4 MUC5AC FBN3 | 1.76e-08 | 891 | 49 | 14 | GO:0005198 |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 4.60e-07 | 26 | 49 | 4 | GO:0050431 | |
| GeneOntologyMolecularFunction | endoribonuclease activity, cleaving miRNA-paired mRNA | 5.90e-06 | 2 | 49 | 2 | GO:0090624 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 3.08e-05 | 73 | 49 | 4 | GO:0050840 | |
| GeneOntologyMolecularFunction | growth factor binding | 3.94e-05 | 156 | 49 | 5 | GO:0019838 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 4.76e-05 | 268 | 49 | 6 | GO:0005539 | |
| GeneOntologyMolecularFunction | microfibril binding | 8.79e-05 | 6 | 49 | 2 | GO:0050436 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase inhibitor activity | 1.27e-04 | 105 | 49 | 4 | GO:0004867 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 3.83e-04 | 12 | 49 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor activity | 4.52e-04 | 13 | 49 | 2 | GO:0005024 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 5.27e-04 | 14 | 49 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | cytokine binding | 5.92e-04 | 157 | 49 | 4 | GO:0019955 | |
| GeneOntologyMolecularFunction | metalloendopeptidase inhibitor activity | 6.93e-04 | 16 | 49 | 2 | GO:0008191 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 9.86e-04 | 180 | 49 | 4 | GO:0004866 | |
| GeneOntologyMolecularFunction | collagen binding | 1.04e-03 | 81 | 49 | 3 | GO:0005518 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein serine/threonine kinase activity | 1.09e-03 | 20 | 49 | 2 | GO:0004675 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 1.14e-03 | 187 | 49 | 4 | GO:0030414 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 1.48e-03 | 201 | 49 | 4 | GO:0061135 | |
| GeneOntologyMolecularFunction | receptor antagonist activity | 2.79e-03 | 32 | 49 | 2 | GO:0048019 | |
| GeneOntologyMolecularFunction | peptidase regulator activity | 3.61e-03 | 257 | 49 | 4 | GO:0061134 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 3.72e-03 | 37 | 49 | 2 | GO:0016891 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 5.70e-03 | 46 | 49 | 2 | GO:0016893 | |
| GeneOntologyMolecularFunction | signaling receptor inhibitor activity | 5.70e-03 | 46 | 49 | 2 | GO:0030547 | |
| GeneOntologyMolecularFunction | miRNA binding | 6.19e-03 | 48 | 49 | 2 | GO:0035198 | |
| GeneOntologyBiologicalProcess | siRNA-mediated gene silencing by mRNA destabilization | 3.59e-05 | 4 | 51 | 2 | GO:0090625 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 3.59e-05 | 4 | 51 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | siRNA-mediated post-transcriptional gene silencing | 3.59e-05 | 4 | 51 | 2 | GO:0140766 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | HSPG2 FAT4 FAT1 FBN2 SLIT1 LAMA3 LAMC1 LAMC3 USH2A MEGF11 NOTCH2 CRB1 | 4.71e-05 | 1269 | 51 | 12 | GO:0009887 |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 5.91e-05 | 276 | 51 | 6 | GO:0007179 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 6.54e-05 | 412 | 51 | 7 | GO:0090287 | |
| GeneOntologyBiologicalProcess | axon guidance | 7.05e-05 | 285 | 51 | 6 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 7.19e-05 | 286 | 51 | 6 | GO:0097485 | |
| GeneOntologyBiologicalProcess | hemidesmosome assembly | 8.93e-05 | 6 | 51 | 2 | GO:0031581 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 1.06e-04 | 445 | 51 | 7 | GO:0141091 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 1.10e-04 | 192 | 51 | 5 | GO:0017015 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 1.18e-04 | 195 | 51 | 5 | GO:1903844 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 1.66e-04 | 8 | 51 | 2 | GO:0071694 | |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | 1.68e-04 | 334 | 51 | 6 | GO:0060249 | |
| GeneOntologyBiologicalProcess | tissue homeostasis | 1.68e-04 | 334 | 51 | 6 | GO:0001894 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 1.73e-04 | 482 | 51 | 7 | GO:0007178 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 1.74e-04 | 336 | 51 | 6 | GO:0071560 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 1.94e-04 | 343 | 51 | 6 | GO:0071559 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2.07e-04 | 347 | 51 | 6 | GO:0090092 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 2.11e-04 | 850 | 51 | 9 | GO:0071363 | |
| GeneOntologyBiologicalProcess | RNA secondary structure unwinding | 2.13e-04 | 9 | 51 | 2 | GO:0010501 | |
| GeneOntologyBiologicalProcess | RISC complex assembly | 2.66e-04 | 10 | 51 | 2 | GO:0070922 | |
| GeneOntologyBiologicalProcess | response to growth factor | 2.79e-04 | 883 | 51 | 9 | GO:0070848 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | 3.13e-04 | 531 | 51 | 7 | GO:0042692 | |
| GeneOntologyBiologicalProcess | sequestering of extracellular ligand from receptor | 3.25e-04 | 11 | 51 | 2 | GO:0035581 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 3.25e-04 | 11 | 51 | 2 | GO:0110011 | |
| GeneOntologyBiologicalProcess | female pregnancy | 3.68e-04 | 249 | 51 | 5 | GO:0007565 | |
| GeneOntologyBiologicalProcess | negative regulation of transforming growth factor beta receptor signaling pathway | 3.76e-04 | 138 | 51 | 4 | GO:0030512 | |
| GeneOntologyBiologicalProcess | axonogenesis | 4.59e-04 | 566 | 51 | 7 | GO:0007409 | |
| GeneOntologyBiologicalProcess | extracellular regulation of signal transduction | 4.59e-04 | 13 | 51 | 2 | GO:1900115 | |
| GeneOntologyBiologicalProcess | extracellular negative regulation of signal transduction | 4.59e-04 | 13 | 51 | 2 | GO:1900116 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 5.35e-04 | 14 | 51 | 2 | GO:2001046 | |
| GeneOntologyBiologicalProcess | multi-organism reproductive process | 7.35e-04 | 290 | 51 | 5 | GO:0044703 | |
| GeneOntologyBiologicalProcess | skeletal system development | 7.50e-04 | 615 | 51 | 7 | GO:0001501 | |
| GeneOntologyBiologicalProcess | multi-multicellular organism process | 7.81e-04 | 294 | 51 | 5 | GO:0044706 | |
| GeneOntologyBiologicalProcess | pre-miRNA processing | 7.96e-04 | 17 | 51 | 2 | GO:0031054 | |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 8.41e-04 | 171 | 51 | 4 | GO:0048593 | |
| GeneOntologyBiologicalProcess | axon development | 9.65e-04 | 642 | 51 | 7 | GO:0061564 | |
| GeneOntologyBiologicalProcess | regulation of trophoblast cell migration | 9.98e-04 | 19 | 51 | 2 | GO:1901163 | |
| GeneOntologyBiologicalProcess | trophoblast cell migration | 1.11e-03 | 20 | 51 | 2 | GO:0061450 | |
| GeneOntologyBiologicalProcess | muscle structure development | 1.13e-03 | 858 | 51 | 8 | GO:0061061 | |
| GeneOntologyBiologicalProcess | negative regulation of protein metabolic process | 1.26e-03 | 1088 | 51 | 9 | GO:0051248 | |
| GeneOntologyBiologicalProcess | regulation of integrin-mediated signaling pathway | 1.47e-03 | 23 | 51 | 2 | GO:2001044 | |
| GeneOntologyBiologicalProcess | eye morphogenesis | 1.61e-03 | 204 | 51 | 4 | GO:0048592 | |
| GeneOntologyCellularComponent | extracellular matrix | AMBP HSPG2 LAMB4 INHBE FCGBP FBN2 MEGF6 ADAMTS3 TFPI2 FGA LAMA3 LAMA4 LAMC1 NID1 LAMC3 LTBP1 LTBP2 USH2A LTBP4 MUC5AC FBN3 | 9.31e-19 | 656 | 51 | 21 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | AMBP HSPG2 LAMB4 INHBE FCGBP FBN2 MEGF6 ADAMTS3 TFPI2 FGA LAMA3 LAMA4 LAMC1 NID1 LAMC3 LTBP1 LTBP2 USH2A LTBP4 MUC5AC FBN3 | 9.91e-19 | 658 | 51 | 21 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | AMBP HSPG2 LAMB4 INHBE FBN2 MEGF6 ADAMTS3 FGA LAMA3 LAMA4 LAMC1 NID1 LAMC3 LTBP1 LTBP2 USH2A LTBP4 | 3.82e-15 | 530 | 51 | 17 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | 5.51e-10 | 122 | 51 | 8 | GO:0005604 | |
| GeneOntologyCellularComponent | microfibril | 2.21e-08 | 13 | 51 | 4 | GO:0001527 | |
| GeneOntologyCellularComponent | laminin complex | 2.59e-04 | 10 | 51 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | RISC-loading complex | 2.59e-04 | 10 | 51 | 2 | GO:0070578 | |
| GeneOntologyCellularComponent | apical part of cell | 5.54e-04 | 592 | 51 | 7 | GO:0045177 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 7.75e-04 | 17 | 51 | 2 | GO:0098637 | |
| GeneOntologyCellularComponent | apical plasma membrane | 1.15e-03 | 487 | 51 | 6 | GO:0016324 | |
| GeneOntologyCellularComponent | Golgi lumen | 2.39e-03 | 109 | 51 | 3 | GO:0005796 | |
| GeneOntologyCellularComponent | synaptic cleft | 2.94e-03 | 33 | 51 | 2 | GO:0043083 | |
| HumanPheno | Pyloric stenosis | 1.11e-07 | 104 | 21 | 7 | HP:0002021 | |
| HumanPheno | Abnormality of the pylorus | 1.35e-07 | 107 | 21 | 7 | HP:0004400 | |
| HumanPheno | Abnormal cranial suture/fontanelle morphology | HSPG2 FAT4 AGO2 SEC24C ADAMTS3 GNPTAB LTBP1 DLK1 LTBP4 NOTCH2 | 5.86e-06 | 472 | 21 | 10 | HP:0000235 |
| HumanPheno | Abnormality of cranial sutures | 1.01e-05 | 388 | 21 | 9 | HP:0011329 | |
| HumanPheno | Inguinal hernia | 1.82e-05 | 312 | 21 | 8 | HP:0000023 | |
| HumanPheno | Hoarse cry | 2.66e-05 | 15 | 21 | 3 | HP:0001615 | |
| HumanPheno | Conductive hearing impairment | 6.68e-05 | 373 | 21 | 8 | HP:0000405 | |
| HumanPheno | Functional abnormality of the middle ear | 8.54e-05 | 386 | 21 | 8 | HP:0011452 | |
| HumanPheno | Wide nasal bridge | 8.91e-05 | 508 | 21 | 9 | HP:0000431 | |
| HumanPheno | Abnormal aortic valve morphology | 1.03e-04 | 289 | 21 | 7 | HP:0001646 | |
| HumanPheno | Abnormal pulmonary valve morphology | 1.06e-04 | 198 | 21 | 6 | HP:0001641 | |
| HumanPheno | Multiple bladder diverticula | 1.61e-04 | 5 | 21 | 2 | HP:0012619 | |
| HumanPheno | Pulmonary lymphangiectasia | 1.61e-04 | 5 | 21 | 2 | HP:0006521 | |
| HumanPheno | Abnormal pulmonary lymphatics | 1.61e-04 | 5 | 21 | 2 | HP:0006529 | |
| HumanPheno | Narrow chest | 1.64e-04 | 133 | 21 | 5 | HP:0000774 | |
| HumanPheno | Abnormal blood vessel morphology | HSPG2 FAT4 AGO2 FBN2 SEC24C ADAMTS3 FGA LAMA4 LTBP1 DLK1 LTBP2 LTBP4 NOTCH2 | 1.92e-04 | 1201 | 21 | 13 | HP:0033353 |
| HumanPheno | Narrow mouth | 2.67e-04 | 234 | 21 | 6 | HP:0000160 | |
| HumanPheno | Abnormal heart valve morphology | 2.79e-04 | 588 | 21 | 9 | HP:0001654 | |
| HumanPheno | Full cheeks | 2.97e-04 | 151 | 21 | 5 | HP:0000293 | |
| HumanPheno | Thoracic hypoplasia | 3.16e-04 | 153 | 21 | 5 | HP:0005257 | |
| HumanPheno | Laryngomalacia | 3.33e-04 | 84 | 21 | 4 | HP:0001601 | |
| HumanPheno | Pulmonary artery stenosis | 3.33e-04 | 84 | 21 | 4 | HP:0004415 | |
| HumanPheno | Abnormal pulmonary valve physiology | 4.23e-04 | 163 | 21 | 5 | HP:0031654 | |
| HumanPheno | Abnormally folded helix | 4.33e-04 | 90 | 21 | 4 | HP:0008544 | |
| HumanPheno | Wrist flexion contracture | 4.64e-04 | 38 | 21 | 3 | HP:0001239 | |
| HumanPheno | Abnormality of the wrist | 4.87e-04 | 168 | 21 | 5 | HP:0003019 | |
| HumanPheno | Abnormal phalangeal joint morphology of the hand | 4.93e-04 | 262 | 21 | 6 | HP:0006261 | |
| HumanPheno | Abnormal vascular morphology | HSPG2 FAT4 AGO2 FBN2 SEC24C ADAMTS3 FGA LAMA4 LTBP1 DLK1 LTBP2 LTBP4 NOTCH2 | 5.24e-04 | 1319 | 21 | 13 | HP:0025015 |
| HumanPheno | Abnormality of the spleen | 5.32e-04 | 640 | 21 | 9 | HP:0001743 | |
| HumanPheno | Peripheral pulmonary artery stenosis | 5.41e-04 | 40 | 21 | 3 | HP:0004969 | |
| HumanPheno | Hernia of the abdominal wall | 5.66e-04 | 506 | 21 | 8 | HP:0004299 | |
| HumanPheno | Abdominal wall defect | 6.05e-04 | 511 | 21 | 8 | HP:0010866 | |
| HumanPheno | Thoracoabdominal wall defect | 6.05e-04 | 511 | 21 | 8 | HP:0100656 | |
| HumanPheno | Glaucoma | 6.41e-04 | 388 | 21 | 7 | HP:0000501 | |
| HumanPheno | Lens dislocation | 6.70e-04 | 43 | 21 | 3 | HP:0000665 | |
| HumanPheno | Ectopia lentis | 6.70e-04 | 43 | 21 | 3 | HP:0001083 | |
| HumanPheno | Lymphangiectasis | 7.14e-04 | 10 | 21 | 2 | HP:0031842 | |
| HumanPheno | Abnormal cheek morphology | 7.30e-04 | 282 | 21 | 6 | HP:0004426 | |
| HumanPheno | Miscarriage | 7.67e-04 | 45 | 21 | 3 | HP:0005268 | |
| HumanPheno | Abnormal heart valve physiology | 8.06e-04 | 403 | 21 | 7 | HP:0031653 | |
| HumanPheno | Flat face | 8.07e-04 | 106 | 21 | 4 | HP:0012368 | |
| HumanPheno | Craniosynostosis | 8.56e-04 | 190 | 21 | 5 | HP:0001363 | |
| HumanPheno | Lymphangioma | 8.71e-04 | 11 | 21 | 2 | HP:0100764 | |
| HumanPheno | Erysipelas | 8.71e-04 | 11 | 21 | 2 | HP:0001055 | |
| HumanPheno | Joint contracture of the hand | 9.44e-04 | 296 | 21 | 6 | HP:0009473 | |
| HumanPheno | Kyphoscoliosis | 9.85e-04 | 196 | 21 | 5 | HP:0002751 | |
| HumanPheno | Abnormal larynx morphology | 1.10e-03 | 201 | 21 | 5 | HP:0025423 | |
| HumanPheno | Abnormality of mouth size | 1.11e-03 | 425 | 21 | 7 | HP:0011337 | |
| HumanPheno | Abnormality of the abdominal wall | 1.12e-03 | 560 | 21 | 8 | HP:0004298 | |
| HumanPheno | Umbilical hernia | 1.12e-03 | 306 | 21 | 6 | HP:0001537 | |
| HumanPheno | Long philtrum | 1.17e-03 | 429 | 21 | 7 | HP:0000343 | |
| HumanPheno | Abnormal umbilicus morphology | 1.27e-03 | 313 | 21 | 6 | HP:0001551 | |
| HumanPheno | Abnormality of globe location or size | HSPG2 FAT4 AGO2 SEC24C ADAMTS3 GNPTAB LTBP1 DLK1 LTBP2 LTBP4 NOTCH2 CRB1 | 1.34e-03 | 1246 | 21 | 12 | HP:0000489 |
| HumanPheno | Abnormality of the philtrum | 1.36e-03 | 726 | 21 | 9 | HP:0000288 | |
| HumanPheno | Abnormal fontanelle morphology | 1.37e-03 | 211 | 21 | 5 | HP:0011328 | |
| HumanPheno | Lower extremity joint dislocation | 1.38e-03 | 318 | 21 | 6 | HP:0030311 | |
| HumanPheno | Pectus excavatum | 1.49e-03 | 323 | 21 | 6 | HP:0000767 | |
| HumanPheno | Abnormality of external features of the abdomen | 1.56e-03 | 326 | 21 | 6 | HP:0001462 | |
| HumanPheno | Hernia | 1.57e-03 | 589 | 21 | 8 | HP:0100790 | |
| HumanPheno | Abnormal stomach morphology | 1.59e-03 | 742 | 21 | 9 | HP:0002577 | |
| HumanPheno | Abnormal hand morphology | HSPG2 FAT4 AGO2 FBN2 SEC24C GNPTAB LAMA3 LTBP1 DLK1 LTBP2 NOTCH2 | 1.60e-03 | 1082 | 21 | 11 | HP:0005922 |
| HumanPheno | Abnormal cornea morphology | 1.62e-03 | 744 | 21 | 9 | HP:0000481 | |
| HumanPheno | Pathologic fracture | 1.69e-03 | 59 | 21 | 3 | HP:0002756 | |
| HumanPheno | Hypoplastic facial bones | 1.69e-03 | 331 | 21 | 6 | HP:0002692 | |
| HumanPheno | Aplasia/Hypoplasia of facial bones | 1.72e-03 | 332 | 21 | 6 | HP:0034261 | |
| HumanPheno | Death in childhood | 1.78e-03 | 131 | 21 | 4 | HP:0003819 | |
| HumanPheno | Wormian bones | 1.86e-03 | 61 | 21 | 3 | HP:0002645 | |
| HumanPheno | Mild postnatal growth retardation | 1.88e-03 | 16 | 21 | 2 | HP:0001530 | |
| HumanPheno | Abnormal placental size | 1.88e-03 | 16 | 21 | 2 | HP:0012767 | |
| HumanPheno | Abnormal pulmonary artery morphology | 1.88e-03 | 133 | 21 | 4 | HP:0030966 | |
| HumanPheno | Hip contracture | 1.95e-03 | 62 | 21 | 3 | HP:0003273 | |
| HumanPheno | Abnormal spleen morphology | 2.04e-03 | 613 | 21 | 8 | HP:0025408 | |
| HumanPheno | Abnormal anterior fontanelle morphology | 2.04e-03 | 136 | 21 | 4 | HP:0000236 | |
| HumanPheno | Epicanthus | 2.06e-03 | 614 | 21 | 8 | HP:0000286 | |
| HumanPheno | Abnormal sternum morphology | 2.11e-03 | 474 | 21 | 7 | HP:0000766 | |
| HumanPheno | Platybasia | 2.12e-03 | 17 | 21 | 2 | HP:0002691 | |
| HumanPheno | Abnormal lymphatic vessel morphology | 2.12e-03 | 17 | 21 | 2 | HP:0100766 | |
| HumanPheno | Camptodactyly | 2.13e-03 | 346 | 21 | 6 | HP:0012385 | |
| HumanPheno | Pulmonic stenosis | 2.16e-03 | 138 | 21 | 4 | HP:0001642 | |
| HumanPheno | Abnormality of globe location | HSPG2 FAT4 AGO2 SEC24C ADAMTS3 GNPTAB LTBP1 DLK1 LTBP4 NOTCH2 CRB1 | 2.19e-03 | 1122 | 21 | 11 | HP:0100886 |
| HumanPheno | Abnormal cardiac ventricle morphology | 2.29e-03 | 780 | 21 | 9 | HP:0001713 | |
| HumanPheno | Abnormality of the gingiva | 2.30e-03 | 237 | 21 | 5 | HP:0000168 | |
| HumanPheno | Abnormal testis morphology | HSPG2 FAT4 SEC24C ADAMTS3 GNPTAB LTBP1 DLK1 USH2A LTBP4 NOTCH2 CRB1 | 2.31e-03 | 1129 | 21 | 11 | HP:0000035 |
| HumanPheno | Non-obstructive azoospermia | HSPG2 FAT4 SEC24C ADAMTS3 GNPTAB LTBP1 DLK1 USH2A LTBP4 NOTCH2 CRB1 | 2.36e-03 | 1132 | 21 | 11 | HP:0011961 |
| HumanPheno | Chylothorax | 2.38e-03 | 18 | 21 | 2 | HP:0010310 | |
| HumanPheno | Abnormality of calvarial morphology | HSPG2 FAT4 AGO2 FBN2 SEC24C ADAMTS3 GNPTAB LTBP1 DLK1 LTBP4 NOTCH2 | 2.40e-03 | 1134 | 21 | 11 | HP:0002648 |
| HumanPheno | Malar flattening | 2.43e-03 | 240 | 21 | 5 | HP:0000272 | |
| HumanPheno | Flexion contracture of finger | 2.43e-03 | 240 | 21 | 5 | HP:0005651 | |
| HumanPheno | Camptodactyly (hands) | 2.43e-03 | 240 | 21 | 5 | HP:0010563 | |
| HumanPheno | Joint contractures involving the joints of the feet | 2.43e-03 | 240 | 21 | 5 | HP:0100492 | |
| HumanPheno | Camptodactyly of finger | 2.43e-03 | 240 | 21 | 5 | HP:0100490 | |
| HumanPheno | Interphalangeal joint contracture of finger | 2.43e-03 | 240 | 21 | 5 | HP:0001220 | |
| HumanPheno | Camptodactyly of toe | 2.43e-03 | 240 | 21 | 5 | HP:0001836 | |
| HumanPheno | Flexion contracture of toe | 2.43e-03 | 240 | 21 | 5 | HP:0005830 | |
| HumanPheno | Abnormal cardiac septum morphology | 2.44e-03 | 787 | 21 | 9 | HP:0001671 | |
| HumanPheno | Abnormal thorax morphology | HSPG2 FAT4 FBN2 SEC24C ADAMTS3 GLDC GNPTAB LTBP1 DLK1 LTBP2 LTBP4 NOTCH2 | 2.44e-03 | 1328 | 21 | 12 | HP:0000765 |
| HumanPheno | Abnormal male external genitalia morphology | HSPG2 FAT4 SEC24C ADAMTS3 GNPTAB LAMA3 LTBP1 DLK1 USH2A LTBP4 NOTCH2 CRB1 | 2.46e-03 | 1329 | 21 | 12 | HP:0000032 |
| HumanPheno | Toe joint contracture | 2.48e-03 | 241 | 21 | 5 | HP:0034675 | |
| HumanPheno | Abnormality of the lymphatic system | 2.57e-03 | 793 | 21 | 9 | HP:0100763 | |
| HumanPheno | Abnormal delivery | 2.58e-03 | 145 | 21 | 4 | HP:0001787 | |
| MousePheno | abnormal basement membrane morphology | 8.60e-06 | 40 | 46 | 4 | MP:0004272 | |
| MousePheno | abnormal ascending aorta and coronary artery attachment | 3.17e-05 | 3 | 46 | 2 | MP:0010472 | |
| MousePheno | abnormal cyst | 4.49e-05 | 294 | 46 | 7 | MP:0031310 | |
| MousePheno | abnormal quadriceps morphology | 7.29e-05 | 25 | 46 | 3 | MP:0010225 | |
| MousePheno | abnormal limb muscle morphology | 9.46e-05 | 73 | 46 | 4 | MP:0021206 | |
| MousePheno | kidney microaneurysm | 1.05e-04 | 5 | 46 | 2 | MP:0010451 | |
| MousePheno | abnormal thoracic cage morphology | 1.18e-04 | 463 | 46 | 8 | MP:0004624 | |
| MousePheno | abnormal skeletal muscle mass | 1.24e-04 | 149 | 46 | 5 | MP:0004817 | |
| MousePheno | increased circulating type I collagen C-terminal telopeptide level | 1.58e-04 | 6 | 46 | 2 | MP:0031074 | |
| MousePheno | increased Schwann cell number | 1.58e-04 | 6 | 46 | 2 | MP:0010742 | |
| MousePheno | abnormal axial skeleton morphology | HSPG2 FAT4 FBN2 PHF19 ADAMTS3 GLDC WFIKKN1 GNPTAB LAMA3 LTBP1 DLK1 SLC4A4 LTBP4 NOTCH2 | 1.63e-04 | 1458 | 46 | 14 | MP:0002114 |
| MousePheno | abnormal rib morphology | 1.84e-04 | 257 | 46 | 6 | MP:0000150 | |
| MousePheno | aneurysm | 2.03e-04 | 35 | 46 | 3 | MP:0003279 | |
| MousePheno | abnormal myelination | 2.06e-04 | 166 | 46 | 5 | MP:0000920 | |
| MousePheno | abnormal Schwann cell morphology | 2.40e-04 | 37 | 46 | 3 | MP:0001106 | |
| MousePheno | abnormal PNS glial cell morphology | 2.40e-04 | 37 | 46 | 3 | MP:0001105 | |
| MousePheno | abnormal skeletal muscle size | 2.42e-04 | 93 | 46 | 4 | MP:0009458 | |
| MousePheno | internal hemorrhage | 2.49e-04 | 387 | 46 | 7 | MP:0001634 | |
| MousePheno | kidney cyst | 2.77e-04 | 177 | 46 | 5 | MP:0003675 | |
| MousePheno | abnormal circulating type I collagen C-terminal telopeptide level | 2.93e-04 | 8 | 46 | 2 | MP:0031072 | |
| MousePheno | abnormal skeletal muscle fiber type ratio | 3.03e-04 | 40 | 46 | 3 | MP:0009409 | |
| MousePheno | abnormal extracellular matrix morphology | 3.19e-04 | 100 | 46 | 4 | MP:0013258 | |
| MousePheno | abnormal vertebrae morphology | 3.62e-04 | 546 | 46 | 8 | MP:0000137 | |
| MousePheno | decreased kidney cell proliferation | 3.76e-04 | 9 | 46 | 2 | MP:0011441 | |
| MousePheno | abnormal somatic nervous system morphology | HSPG2 FAT4 FBN2 ADAMTS3 GNPTAB SLC44A2 LAMA4 LAMC3 USH2A MEGF11 CRB1 | 3.83e-04 | 1025 | 46 | 11 | MP:0002752 |
| MousePheno | impaired basement membrane formation | 5.72e-04 | 11 | 46 | 2 | MP:0003044 | |
| MousePheno | decreased quadriceps weight | 5.72e-04 | 11 | 46 | 2 | MP:0010227 | |
| MousePheno | skin hemorrhage | 6.85e-04 | 12 | 46 | 2 | MP:0011514 | |
| MousePheno | abnormal pericardial cavity morphology | 8.13e-04 | 128 | 46 | 4 | MP:0012501 | |
| MousePheno | abnormal ureteric bud morphology | 8.62e-04 | 57 | 46 | 3 | MP:0006032 | |
| MousePheno | abnormal vertebral column morphology | 9.11e-04 | 787 | 46 | 9 | MP:0004703 | |
| Domain | EGF_1 | HSPG2 LAMB4 FAT4 FAT1 STAB2 FBN2 MEGF6 SLIT1 LAMA3 LAMA4 LAMC1 NID1 LAMC3 LTBP1 DLK1 LTBP2 C7 MUC13 USH2A LTBP4 MEGF11 FBN3 NOTCH2 CRB1 | 9.72e-32 | 255 | 51 | 24 | PS00022 |
| Domain | EGF-like_dom | HSPG2 FAT4 FAT1 STAB2 FCGBP FBN2 MEGF6 SLIT1 LAMA3 LAMA4 LAMC1 NID1 LAMC3 LTBP1 DLK1 LTBP2 C7 MUC13 LTBP4 MEGF11 FBN3 NOTCH2 CRB1 | 3.76e-30 | 249 | 51 | 23 | IPR000742 |
| Domain | EGF-like_CS | HSPG2 LAMB4 FAT4 FAT1 STAB2 FBN2 MEGF6 SLIT1 LAMA3 LAMA4 LAMC1 NID1 LAMC3 LTBP1 DLK1 LTBP2 C7 MUC13 LTBP4 MEGF11 FBN3 NOTCH2 CRB1 | 1.15e-29 | 261 | 51 | 23 | IPR013032 |
| Domain | EGF | HSPG2 FAT4 FAT1 STAB2 FCGBP FBN2 MEGF6 SLIT1 LAMA3 LAMA4 LAMC1 NID1 LAMC3 LTBP1 DLK1 LTBP2 MUC13 LTBP4 MEGF11 FBN3 NOTCH2 CRB1 | 6.52e-29 | 235 | 51 | 22 | SM00181 |
| Domain | EGF_2 | HSPG2 LAMB4 FAT4 FAT1 STAB2 FBN2 MEGF6 SLIT1 LAMA3 LAMC1 NID1 LAMC3 LTBP1 DLK1 LTBP2 C7 MUC13 LTBP4 MEGF11 FBN3 NOTCH2 CRB1 | 9.87e-28 | 265 | 51 | 22 | PS01186 |
| Domain | Growth_fac_rcpt_ | HSPG2 FAT4 FAT1 STAB2 FBN2 MEGF6 SLIT1 LAMA3 LAMC1 NID1 LAMC3 LTBP1 LTBP2 MUC13 LTBP4 FBN3 NOTCH2 CRB1 | 3.15e-25 | 156 | 51 | 18 | IPR009030 |
| Domain | EGF_3 | HSPG2 FAT4 FAT1 STAB2 FBN2 MEGF6 SLIT1 NID1 LTBP1 DLK1 LTBP2 C7 MUC13 LTBP4 MEGF11 FBN3 NOTCH2 CRB1 | 6.25e-22 | 235 | 51 | 18 | PS50026 |
| Domain | EGF_CA | HSPG2 FAT4 FAT1 STAB2 FBN2 MEGF6 SLIT1 NID1 LTBP1 DLK1 LTBP2 LTBP4 FBN3 NOTCH2 CRB1 | 1.81e-21 | 122 | 51 | 15 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | HSPG2 FAT4 FAT1 STAB2 FBN2 MEGF6 SLIT1 NID1 LTBP1 DLK1 LTBP2 LTBP4 FBN3 NOTCH2 CRB1 | 2.34e-21 | 124 | 51 | 15 | IPR001881 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | FAT4 FAT1 FBN2 MEGF6 SLIT1 NID1 LTBP1 DLK1 LTBP2 LTBP4 FBN3 NOTCH2 CRB1 | 1.18e-18 | 106 | 51 | 13 | IPR000152 |
| Domain | EGF_Lam | HSPG2 LAMB4 STAB2 MEGF6 LAMA3 LAMA4 LAMC1 LAMC3 USH2A MEGF11 | 1.57e-18 | 35 | 51 | 10 | SM00180 |
| Domain | Laminin_EGF | HSPG2 LAMB4 STAB2 MEGF6 LAMA3 LAMA4 LAMC1 LAMC3 USH2A MEGF11 | 4.02e-18 | 38 | 51 | 10 | IPR002049 |
| Domain | EGF_Ca-bd_CS | FAT4 FAT1 FBN2 MEGF6 SLIT1 NID1 LTBP1 LTBP2 LTBP4 FBN3 NOTCH2 CRB1 | 2.56e-17 | 97 | 51 | 12 | IPR018097 |
| Domain | EGF_CA | FAT4 FAT1 FBN2 MEGF6 SLIT1 NID1 LTBP1 LTBP2 LTBP4 FBN3 NOTCH2 CRB1 | 3.31e-17 | 99 | 51 | 12 | PS01187 |
| Domain | ASX_HYDROXYL | FAT4 FAT1 FBN2 MEGF6 NID1 LTBP1 DLK1 LTBP2 LTBP4 FBN3 NOTCH2 CRB1 | 3.75e-17 | 100 | 51 | 12 | PS00010 |
| Domain | Laminin_EGF | 2.68e-16 | 35 | 51 | 9 | PF00053 | |
| Domain | EGF | HSPG2 FAT1 STAB2 MEGF6 SLIT1 NID1 LTBP1 DLK1 LTBP2 FBN3 NOTCH2 CRB1 | 6.61e-16 | 126 | 51 | 12 | PF00008 |
| Domain | hEGF | 5.18e-15 | 28 | 51 | 8 | PF12661 | |
| Domain | EGF_LAM_2 | 9.72e-15 | 30 | 51 | 8 | PS50027 | |
| Domain | EGF_LAM_1 | 9.72e-15 | 30 | 51 | 8 | PS01248 | |
| Domain | EGF_CA | 2.74e-14 | 86 | 51 | 10 | PF07645 | |
| Domain | LAM_G_DOMAIN | 7.99e-14 | 38 | 51 | 8 | PS50025 | |
| Domain | Laminin_G_2 | 1.25e-13 | 40 | 51 | 8 | PF02210 | |
| Domain | LamG | 2.86e-13 | 44 | 51 | 8 | SM00282 | |
| Domain | TB | 2.60e-12 | 7 | 51 | 5 | PF00683 | |
| Domain | Laminin_G | 3.00e-12 | 58 | 51 | 8 | IPR001791 | |
| Domain | - | 6.91e-12 | 8 | 51 | 5 | 3.90.290.10 | |
| Domain | TB | 1.55e-11 | 9 | 51 | 5 | PS51364 | |
| Domain | TB_dom | 1.55e-11 | 9 | 51 | 5 | IPR017878 | |
| Domain | - | 1.77e-10 | 95 | 51 | 8 | 2.60.120.200 | |
| Domain | Laminin_N | 5.30e-10 | 16 | 51 | 5 | IPR008211 | |
| Domain | LAMININ_NTER | 5.30e-10 | 16 | 51 | 5 | PS51117 | |
| Domain | Laminin_N | 5.30e-10 | 16 | 51 | 5 | PF00055 | |
| Domain | LamNT | 5.30e-10 | 16 | 51 | 5 | SM00136 | |
| Domain | LAMININ_IVA | 3.42e-09 | 8 | 51 | 4 | PS51115 | |
| Domain | Laminin_B | 3.42e-09 | 8 | 51 | 4 | PF00052 | |
| Domain | LamB | 3.42e-09 | 8 | 51 | 4 | SM00281 | |
| Domain | Laminin_IV | 3.42e-09 | 8 | 51 | 4 | IPR000034 | |
| Domain | ConA-like_dom | 1.30e-07 | 219 | 51 | 8 | IPR013320 | |
| Domain | - | 1.47e-07 | 18 | 51 | 4 | 4.10.410.10 | |
| Domain | Prtase_inh_Kunz-CS | 1.47e-07 | 18 | 51 | 4 | IPR020901 | |
| Domain | KU | 1.47e-07 | 18 | 51 | 4 | SM00131 | |
| Domain | BPTI_KUNITZ_2 | 1.85e-07 | 19 | 51 | 4 | PS50279 | |
| Domain | Kunitz_BPTI | 1.85e-07 | 19 | 51 | 4 | PF00014 | |
| Domain | BPTI_KUNITZ_1 | 1.85e-07 | 19 | 51 | 4 | PS00280 | |
| Domain | Kunitz_BPTI | 4.20e-07 | 23 | 51 | 4 | IPR002223 | |
| Domain | EGF_extracell | 6.05e-07 | 60 | 51 | 5 | IPR013111 | |
| Domain | EGF_2 | 6.05e-07 | 60 | 51 | 5 | PF07974 | |
| Domain | cEGF | 7.05e-07 | 26 | 51 | 4 | IPR026823 | |
| Domain | cEGF | 7.05e-07 | 26 | 51 | 4 | PF12662 | |
| Domain | FBN | 2.19e-05 | 3 | 51 | 2 | IPR011398 | |
| Domain | Argonaute_N | 4.37e-05 | 4 | 51 | 2 | IPR032474 | |
| Domain | Argonaute_Mid_dom | 4.37e-05 | 4 | 51 | 2 | IPR032473 | |
| Domain | ArgoL2 | 4.37e-05 | 4 | 51 | 2 | IPR032472 | |
| Domain | ArgoN | 4.37e-05 | 4 | 51 | 2 | PF16486 | |
| Domain | ArgoMid | 4.37e-05 | 4 | 51 | 2 | PF16487 | |
| Domain | ArgoL2 | 4.37e-05 | 4 | 51 | 2 | PF16488 | |
| Domain | Laminin_aI | 7.27e-05 | 5 | 51 | 2 | IPR009254 | |
| Domain | Laminin_I | 7.27e-05 | 5 | 51 | 2 | PF06008 | |
| Domain | Laminin_II | 7.27e-05 | 5 | 51 | 2 | PF06009 | |
| Domain | Laminin_domII | 7.27e-05 | 5 | 51 | 2 | IPR010307 | |
| Domain | LNR | 7.27e-05 | 5 | 51 | 2 | PS50258 | |
| Domain | DUF1785 | 7.27e-05 | 5 | 51 | 2 | SM01163 | |
| Domain | ArgoL1 | 1.09e-04 | 6 | 51 | 2 | PF08699 | |
| Domain | ArgoL1 | 1.09e-04 | 6 | 51 | 2 | IPR014811 | |
| Domain | Kazal_2 | 1.29e-04 | 36 | 51 | 3 | PF07648 | |
| Domain | Notch_dom | 1.52e-04 | 7 | 51 | 2 | IPR000800 | |
| Domain | Notch | 1.52e-04 | 7 | 51 | 2 | PF00066 | |
| Domain | NL | 1.52e-04 | 7 | 51 | 2 | SM00004 | |
| Domain | PIWI | 2.03e-04 | 8 | 51 | 2 | PS50822 | |
| Domain | Piwi | 2.03e-04 | 8 | 51 | 2 | SM00950 | |
| Domain | Piwi | 2.03e-04 | 8 | 51 | 2 | IPR003165 | |
| Domain | Piwi | 2.03e-04 | 8 | 51 | 2 | PF02171 | |
| Domain | PAZ | 2.60e-04 | 9 | 51 | 2 | PS50821 | |
| Domain | PAZ | 2.60e-04 | 9 | 51 | 2 | SM00949 | |
| Domain | PAZ_dom | 2.60e-04 | 9 | 51 | 2 | IPR003100 | |
| Domain | PAZ | 2.60e-04 | 9 | 51 | 2 | PF02170 | |
| Domain | KAZAL | 2.68e-04 | 46 | 51 | 3 | SM00280 | |
| Domain | KAZAL_2 | 3.43e-04 | 50 | 51 | 3 | PS51465 | |
| Domain | Kazal_dom | 3.64e-04 | 51 | 51 | 3 | IPR002350 | |
| Domain | Fol_N | 3.96e-04 | 11 | 51 | 2 | IPR003645 | |
| Domain | - | 3.96e-04 | 11 | 51 | 2 | 2.40.155.10 | |
| Domain | GFP-like | 3.96e-04 | 11 | 51 | 2 | IPR023413 | |
| Domain | FOLN | 3.96e-04 | 11 | 51 | 2 | SM00274 | |
| Domain | EGF_3 | 4.74e-04 | 12 | 51 | 2 | PF12947 | |
| Domain | TIL | 4.74e-04 | 12 | 51 | 2 | PF01826 | |
| Domain | EGF_dom | 4.74e-04 | 12 | 51 | 2 | IPR024731 | |
| Domain | C8 | 4.74e-04 | 12 | 51 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 5.59e-04 | 13 | 51 | 2 | IPR014853 | |
| Domain | C8 | 5.59e-04 | 13 | 51 | 2 | SM00832 | |
| Domain | SEA | 6.51e-04 | 14 | 51 | 2 | SM00200 | |
| Domain | TIL_dom | 6.51e-04 | 14 | 51 | 2 | IPR002919 | |
| Domain | TSP_1 | 6.79e-04 | 63 | 51 | 3 | PF00090 | |
| Domain | TSP1 | 7.44e-04 | 65 | 51 | 3 | SM00209 | |
| Domain | TSP1_rpt | 7.44e-04 | 65 | 51 | 3 | IPR000884 | |
| Domain | TSP1 | 7.44e-04 | 65 | 51 | 3 | PS50092 | |
| Domain | VWD | 8.56e-04 | 16 | 51 | 2 | SM00216 | |
| Domain | WAP | 8.56e-04 | 16 | 51 | 2 | SM00217 | |
| Domain | EMI_domain | 8.56e-04 | 16 | 51 | 2 | IPR011489 | |
| Domain | VWF_type-D | 8.56e-04 | 16 | 51 | 2 | IPR001846 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | HSPG2 FBN2 ADAMTS3 FGA LAMA3 LAMA4 LAMC1 NID1 LAMC3 LTBP1 LTBP2 LTBP4 FBN3 | 1.46e-12 | 300 | 41 | 13 | M610 |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.33e-10 | 30 | 41 | 6 | M27216 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 4.21e-08 | 258 | 41 | 9 | MM14572 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 6.58e-08 | 37 | 41 | 5 | M27134 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.42e-07 | 84 | 41 | 6 | M7098 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.62e-07 | 44 | 41 | 5 | M26969 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 7.21e-07 | 59 | 41 | 5 | M27218 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 7.45e-07 | 25 | 41 | 4 | M39713 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.27e-06 | 66 | 41 | 5 | M18 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.60e-06 | 30 | 41 | 4 | M27772 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.09e-06 | 32 | 41 | 4 | MM14854 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.91e-06 | 140 | 41 | 6 | M587 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 4.22e-06 | 84 | 41 | 5 | M3228 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 4.71e-06 | 39 | 41 | 4 | MM14601 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 5.77e-06 | 41 | 41 | 4 | M27778 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 8.14e-06 | 96 | 41 | 5 | M39834 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 9.20e-06 | 46 | 41 | 4 | M239 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.01e-05 | 15 | 41 | 3 | MM14922 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 4.38e-05 | 68 | 41 | 4 | M27303 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 5.59e-05 | 143 | 41 | 5 | M27275 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 6.79e-05 | 76 | 41 | 4 | M27219 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 7.90e-05 | 79 | 41 | 4 | M27643 | |
| Pathway | BIOCARTA_DICER_PATHWAY | 8.21e-05 | 5 | 41 | 2 | M22079 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 9.82e-05 | 161 | 41 | 5 | M27871 | |
| Pathway | REACTOME_MICRORNA_MIRNA_BIOGENESIS | 1.23e-04 | 6 | 41 | 2 | MM14818 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 1.23e-04 | 6 | 41 | 2 | MM15083 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 1.72e-04 | 7 | 41 | 2 | M46421 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 1.79e-04 | 38 | 41 | 3 | MM14874 | |
| Pathway | REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS | 2.29e-04 | 8 | 41 | 2 | MM15082 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 2.29e-04 | 8 | 41 | 2 | M47850 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 2.60e-04 | 43 | 41 | 3 | M53 | |
| Pathway | KEGG_FOCAL_ADHESION | 2.64e-04 | 199 | 41 | 5 | M7253 | |
| Pathway | REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS | 2.93e-04 | 9 | 41 | 2 | M27340 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 2.93e-04 | 9 | 41 | 2 | M27810 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 2.93e-04 | 9 | 41 | 2 | M46436 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 3.39e-04 | 47 | 41 | 3 | M646 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS | 3.66e-04 | 10 | 41 | 2 | M48013 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 4.46e-04 | 11 | 41 | 2 | M158 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 6.31e-04 | 13 | 41 | 2 | M46434 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 7.50e-04 | 250 | 41 | 5 | M27554 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 9.65e-04 | 16 | 41 | 2 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 1.09e-03 | 17 | 41 | 2 | M27412 | |
| Pathway | REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY | 1.09e-03 | 17 | 41 | 2 | M27788 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS | 1.37e-03 | 19 | 41 | 2 | M48238 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.37e-03 | 19 | 41 | 2 | MM15512 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 1.44e-03 | 77 | 41 | 3 | MM14670 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.67e-03 | 21 | 41 | 2 | MM15706 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.01e-03 | 23 | 41 | 2 | M556 | |
| Pathway | WP_FOCAL_ADHESION | 2.07e-03 | 187 | 41 | 4 | MM15913 | |
| Pathway | REACTOME_MICRORNA_MIRNA_BIOGENESIS | 2.37e-03 | 25 | 41 | 2 | M712 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 2.40e-03 | 325 | 41 | 5 | M12868 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 2.55e-03 | 94 | 41 | 3 | M1041 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 2.57e-03 | 26 | 41 | 2 | M27483 | |
| Pathway | WP_FOCAL_ADHESION | 2.59e-03 | 199 | 41 | 4 | M39402 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 2.63e-03 | 95 | 41 | 3 | M48268 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 2.70e-03 | 96 | 41 | 3 | M39581 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 2.77e-03 | 27 | 41 | 2 | M39545 | |
| Pathway | WP_PI3KAKT_SIGNALING | 2.87e-03 | 339 | 41 | 5 | M39736 | |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 2.97e-03 | 28 | 41 | 2 | M48253 | |
| Pathway | WP_CANCER_PATHWAYS | 3.24e-03 | 507 | 41 | 6 | M48302 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 3.41e-03 | 30 | 41 | 2 | MM15517 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 3.64e-03 | 31 | 41 | 2 | MM1343 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.87e-03 | 109 | 41 | 3 | MM15164 | |
| Pathway | REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION | 3.87e-03 | 32 | 41 | 2 | M48012 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 3.87e-03 | 32 | 41 | 2 | M27900 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 4.07e-03 | 111 | 41 | 3 | M27416 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 4.12e-03 | 33 | 41 | 2 | M39503 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 4.12e-03 | 33 | 41 | 2 | M6220 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4 | 4.37e-03 | 34 | 41 | 2 | M46422 | |
| Pathway | KEGG_PRION_DISEASES | 4.62e-03 | 35 | 41 | 2 | M13036 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_STIMULATED_BY_ALK_SIGNALING_IN_CANCER | 4.62e-03 | 35 | 41 | 2 | M42525 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 4.72e-03 | 117 | 41 | 3 | M19248 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 4.83e-03 | 118 | 41 | 3 | MM15588 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 4.95e-03 | 119 | 41 | 3 | M607 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 5.07e-03 | 120 | 41 | 3 | MM14982 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 5.15e-03 | 37 | 41 | 2 | M29790 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 5.52e-03 | 246 | 41 | 4 | M10189 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 5.55e-03 | 124 | 41 | 3 | M27285 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 6.91e-03 | 43 | 41 | 2 | M39565 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 7.31e-03 | 137 | 41 | 3 | M48232 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 8.21e-03 | 47 | 41 | 2 | M29777 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 8.90e-03 | 49 | 41 | 2 | MM14837 | |
| Pathway | REACTOME_SIGNALING_BY_TGFBR3 | 8.90e-03 | 49 | 41 | 2 | M48250 | |
| Pubmed | HSPG2 FBN2 MEGF6 FGA LAMA3 LAMA4 LAMC1 NID1 LTBP1 LTBP2 LTBP4 | 1.52e-15 | 175 | 51 | 11 | 28071719 | |
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 3.63e-14 | 15 | 51 | 6 | 15895400 | |
| Pubmed | 5.35e-14 | 167 | 51 | 10 | 22159717 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 4.04e-13 | 135 | 51 | 9 | 28675934 | |
| Pubmed | 1.26e-12 | 153 | 51 | 9 | 25037231 | ||
| Pubmed | 4.35e-12 | 12 | 51 | 5 | 16750824 | ||
| Pubmed | 4.34e-11 | 146 | 51 | 8 | 27068509 | ||
| Pubmed | 4.68e-11 | 18 | 51 | 5 | 11311202 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 1.10e-10 | 97 | 51 | 7 | 27559042 | |
| Pubmed | 1.43e-10 | 7 | 51 | 4 | 7921537 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | HSPG2 FAT4 FAT1 FBN2 SEC24C TFPI2 GNPTAB LAMA4 LAMC1 NID1 LAMC3 LTBP1 LTBP2 NOTCH2 | 1.25e-09 | 1201 | 51 | 14 | 35696571 |
| Pubmed | 1.34e-09 | 11 | 51 | 4 | 12051813 | ||
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 1.34e-09 | 11 | 51 | 4 | 21524702 | |
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 1.88e-09 | 79 | 51 | 6 | 18757743 | |
| Pubmed | Basement membranes in skin are differently affected by lack of nidogen 1 and 2. | 2.90e-09 | 13 | 51 | 4 | 18356808 | |
| Pubmed | 7.37e-09 | 16 | 51 | 4 | 17601529 | ||
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 8.36e-09 | 101 | 51 | 6 | 20551380 | |
| Pubmed | 1.19e-08 | 4 | 51 | 3 | 12429738 | ||
| Pubmed | 1.19e-08 | 4 | 51 | 3 | 15611103 | ||
| Pubmed | The latent transforming growth factor beta binding protein (LTBP) family. | 1.19e-08 | 4 | 51 | 3 | 11104663 | |
| Pubmed | 1.95e-08 | 20 | 51 | 4 | 22911573 | ||
| Pubmed | Schwann cell myelination requires integration of laminin activities. | 2.41e-08 | 21 | 51 | 4 | 22767514 | |
| Pubmed | 2.96e-08 | 5 | 51 | 3 | 7670489 | ||
| Pubmed | 2.96e-08 | 5 | 51 | 3 | 12243745 | ||
| Pubmed | Renal collecting system growth and function depend upon embryonic γ1 laminin expression. | 3.56e-08 | 23 | 51 | 4 | 21903675 | |
| Pubmed | 3.96e-08 | 64 | 51 | 5 | 22261194 | ||
| Pubmed | Nidogen-2: a new basement membrane protein with diverse binding properties. | 5.92e-08 | 6 | 51 | 3 | 9733643 | |
| Pubmed | 5.99e-08 | 26 | 51 | 4 | 24742657 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 7.63e-08 | 248 | 51 | 7 | 24006456 | |
| Pubmed | 1.04e-07 | 7 | 51 | 3 | 10930463 | ||
| Pubmed | 1.65e-07 | 8 | 51 | 3 | 12015298 | ||
| Pubmed | 1.65e-07 | 8 | 51 | 3 | 9852162 | ||
| Pubmed | Cleavage of nidogen-1 by cathepsin S impairs its binding to basement membrane partners. | 2.48e-07 | 9 | 51 | 3 | 22952693 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | 3.43e-07 | 1070 | 51 | 11 | 23533145 | |
| Pubmed | 3.54e-07 | 10 | 51 | 3 | 9034910 | ||
| Pubmed | Generation of a conditionally null allele of the laminin alpha1 gene. | 3.54e-07 | 10 | 51 | 3 | 16100707 | |
| Pubmed | 3.54e-07 | 10 | 51 | 3 | 11784026 | ||
| Pubmed | 4.86e-07 | 11 | 51 | 3 | 21084308 | ||
| Pubmed | SVEP1 is an endogenous ligand for the orphan receptor PEAR1. | 4.86e-07 | 11 | 51 | 3 | 36792666 | |
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 4.86e-07 | 11 | 51 | 3 | 23472759 | |
| Pubmed | 6.47e-07 | 12 | 51 | 3 | 16024816 | ||
| Pubmed | 6.47e-07 | 12 | 51 | 3 | 9396756 | ||
| Pubmed | 8.27e-07 | 49 | 51 | 4 | 21362503 | ||
| Pubmed | 8.41e-07 | 13 | 51 | 3 | 12682087 | ||
| Pubmed | 8.41e-07 | 13 | 51 | 3 | 22222602 | ||
| Pubmed | Fukutin-related protein alters the deposition of laminin in the eye and brain. | 8.41e-07 | 13 | 51 | 3 | 21900571 | |
| Pubmed | 8.98e-07 | 50 | 51 | 4 | 23658023 | ||
| Pubmed | 1.33e-06 | 15 | 51 | 3 | 10625553 | ||
| Pubmed | 1.64e-06 | 16 | 51 | 3 | 15878328 | ||
| Pubmed | 1.64e-06 | 16 | 51 | 3 | 30579834 | ||
| Pubmed | Patterns of laminins and integrins in the embryonic ventricular zone of the CNS. | 1.64e-06 | 16 | 51 | 3 | 17948866 | |
| Pubmed | 1.64e-06 | 16 | 51 | 3 | 16880404 | ||
| Pubmed | 1.99e-06 | 17 | 51 | 3 | 21983115 | ||
| Pubmed | The dermal-epidermal junction of human skin contains a novel laminin variant. | 2.11e-06 | 2 | 51 | 2 | 1383241 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 28252045 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 25858550 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 11928817 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 12709070 | ||
| Pubmed | [Complex between nidogen and laminin fragments reveals a paradigmatic beta-propeller interface]. | 2.11e-06 | 2 | 51 | 2 | 14619418 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 23836919 | ||
| Pubmed | Laminin gamma3 chain binds to nidogen and is located in murine basement membranes. | 2.11e-06 | 2 | 51 | 2 | 15824114 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 23674478 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 8077230 | ||
| Pubmed | Crystal structure and mutational analysis of a perlecan-binding fragment of nidogen-1. | 2.11e-06 | 2 | 51 | 2 | 11427896 | |
| Pubmed | Human Argonaute2 and Argonaute3 are catalytically activated by different lengths of guide RNA. | 2.11e-06 | 2 | 51 | 2 | 33122430 | |
| Pubmed | Complex between nidogen and laminin fragments reveals a paradigmatic beta-propeller interface. | 2.11e-06 | 2 | 51 | 2 | 12931195 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 11574465 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 25387007 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 21634124 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 22876132 | ||
| Pubmed | 2.39e-06 | 18 | 51 | 3 | 12571105 | ||
| Pubmed | 3.71e-06 | 71 | 51 | 4 | 33541421 | ||
| Pubmed | 4.49e-06 | 22 | 51 | 3 | 18448648 | ||
| Pubmed | 5.61e-06 | 173 | 51 | 5 | 23979707 | ||
| Pubmed | Turning catalytically inactive human Argonaute proteins into active slicer enzymes. | 6.32e-06 | 3 | 51 | 2 | 23665583 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 1680863 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 9043083 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 9019243 | ||
| Pubmed | The roles of individual mammalian argonautes in RNA interference in vivo. | 6.32e-06 | 3 | 51 | 2 | 24992693 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 21276136 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 17293099 | ||
| Pubmed | WFIKKN1 and WFIKKN2: "Companion" proteins regulating TGFB activity. | 6.32e-06 | 3 | 51 | 2 | 27325460 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 18697739 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 15284456 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 10743502 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 7.54e-06 | 26 | 51 | 3 | 34189436 | |
| Pubmed | PTEN dephosphorylates Abi1 to promote epithelial morphogenesis. | 7.54e-06 | 26 | 51 | 3 | 32673396 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 7.97e-06 | 86 | 51 | 4 | 28327460 | |
| Pubmed | 1.06e-05 | 29 | 51 | 3 | 22613833 | ||
| Pubmed | Notch signaling in stomach epithelial stem cell homeostasis. | 1.06e-05 | 29 | 51 | 3 | 21402740 | |
| Pubmed | Molecular dissection of human Argonaute proteins by DNA shuffling. | 1.26e-05 | 4 | 51 | 2 | 23748378 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 24951930 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 12588956 | ||
| Pubmed | Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. | 1.26e-05 | 4 | 51 | 2 | 15260970 | |
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 1.26e-05 | 4 | 51 | 2 | 25034023 | |
| Pubmed | Utility of molecular testing for related retinal dystrophies. | 1.26e-05 | 4 | 51 | 2 | 16767206 | |
| Pubmed | Binding of netrin-4 to laminin short arms regulates basement membrane assembly. | 1.26e-05 | 4 | 51 | 2 | 17588941 | |
| Pubmed | Both WFIKKN1 and WFIKKN2 have high affinity for growth and differentiation factors 8 and 11. | 1.26e-05 | 4 | 51 | 2 | 18596030 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 36073544 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 9885251 | ||
| Interaction | FBXO2 interactions | 6.76e-08 | 411 | 51 | 10 | int:FBXO2 | |
| Interaction | NID1 interactions | 1.34e-07 | 48 | 51 | 5 | int:NID1 | |
| Interaction | NTN5 interactions | 3.72e-07 | 24 | 51 | 4 | int:NTN5 | |
| Interaction | ZNF408 interactions | 1.72e-06 | 145 | 51 | 6 | int:ZNF408 | |
| Interaction | ATN1 interactions | 7.50e-06 | 187 | 51 | 6 | int:ATN1 | |
| Interaction | ZFP41 interactions | 1.30e-05 | 57 | 51 | 4 | int:ZFP41 | |
| Interaction | ZNF627 interactions | 1.69e-05 | 20 | 51 | 3 | int:ZNF627 | |
| Interaction | FBN2 interactions | 2.20e-05 | 65 | 51 | 4 | int:FBN2 | |
| Interaction | DTX4 interactions | 2.27e-05 | 22 | 51 | 3 | int:DTX4 | |
| Interaction | ELN interactions | 5.33e-05 | 29 | 51 | 3 | int:ELN | |
| Interaction | COL4A3 interactions | 5.91e-05 | 30 | 51 | 3 | int:COL4A3 | |
| Interaction | NID2 interactions | 6.63e-05 | 86 | 51 | 4 | int:NID2 | |
| Interaction | PRG2 interactions | 8.01e-05 | 285 | 51 | 6 | int:PRG2 | |
| Interaction | NOTCH2 interactions | 8.91e-05 | 423 | 51 | 7 | int:NOTCH2 | |
| Interaction | GREM2 interactions | 1.12e-04 | 37 | 51 | 3 | int:GREM2 | |
| Interaction | ZNF594 interactions | 1.31e-04 | 7 | 51 | 2 | int:ZNF594 | |
| Interaction | TRIM66 interactions | 1.67e-04 | 205 | 51 | 5 | int:TRIM66 | |
| Interaction | LGALS3 interactions | 2.10e-04 | 340 | 51 | 6 | int:LGALS3 | |
| Interaction | ZNF480 interactions | 2.23e-04 | 9 | 51 | 2 | int:ZNF480 | |
| Interaction | ZKSCAN2 interactions | 2.23e-04 | 9 | 51 | 2 | int:ZKSCAN2 | |
| Interaction | CEACAM8 interactions | 2.33e-04 | 119 | 51 | 4 | int:CEACAM8 | |
| Interaction | LLCFC1 interactions | 2.48e-04 | 121 | 51 | 4 | int:LLCFC1 | |
| Interaction | FOXD4L6 interactions | 2.59e-04 | 49 | 51 | 3 | int:FOXD4L6 | |
| Interaction | CACNA1A interactions | 2.65e-04 | 123 | 51 | 4 | int:CACNA1A | |
| Interaction | ZNF766 interactions | 2.79e-04 | 10 | 51 | 2 | int:ZNF766 | |
| Interaction | ZDHHC15 interactions | 2.81e-04 | 125 | 51 | 4 | int:ZDHHC15 | |
| Interaction | FBN1 interactions | 2.92e-04 | 51 | 51 | 3 | int:FBN1 | |
| Interaction | MFAP5 interactions | 3.09e-04 | 52 | 51 | 3 | int:MFAP5 | |
| Interaction | FBLN1 interactions | 3.17e-04 | 129 | 51 | 4 | int:FBLN1 | |
| Interaction | PEX5L interactions | 3.46e-04 | 54 | 51 | 3 | int:PEX5L | |
| Interaction | ZNF555 interactions | 4.08e-04 | 12 | 51 | 2 | int:ZNF555 | |
| Interaction | ZNF611 interactions | 4.08e-04 | 12 | 51 | 2 | int:ZNF611 | |
| Interaction | ZNF709 interactions | 4.81e-04 | 13 | 51 | 2 | int:ZNF709 | |
| Interaction | PLAT interactions | 5.45e-04 | 63 | 51 | 3 | int:PLAT | |
| Interaction | HRG interactions | 5.45e-04 | 63 | 51 | 3 | int:HRG | |
| Interaction | ZNF263 interactions | 5.47e-04 | 149 | 51 | 4 | int:ZNF263 | |
| Interaction | VWCE interactions | 5.71e-04 | 64 | 51 | 3 | int:VWCE | |
| Interaction | FBLN2 interactions | 6.24e-04 | 66 | 51 | 3 | int:FBLN2 | |
| Interaction | LAMA1 interactions | 6.24e-04 | 66 | 51 | 3 | int:LAMA1 | |
| Interaction | PRSS37 interactions | 6.46e-04 | 15 | 51 | 2 | int:PRSS37 | |
| Interaction | LTBP4 interactions | 6.53e-04 | 67 | 51 | 3 | int:LTBP4 | |
| Interaction | TIMP2 interactions | 6.63e-04 | 277 | 51 | 5 | int:TIMP2 | |
| Interaction | ZNF696 interactions | 6.81e-04 | 68 | 51 | 3 | int:ZNF696 | |
| Interaction | ZNF260 interactions | 7.37e-04 | 16 | 51 | 2 | int:ZNF260 | |
| Interaction | ZNF628 interactions | 7.37e-04 | 16 | 51 | 2 | int:ZNF628 | |
| Interaction | CDH23 interactions | 7.73e-04 | 71 | 51 | 3 | int:CDH23 | |
| Interaction | KLKB1 interactions | 8.33e-04 | 17 | 51 | 2 | int:KLKB1 | |
| Interaction | F2 interactions | 8.72e-04 | 74 | 51 | 3 | int:F2 | |
| Interaction | IGFL3 interactions | 9.07e-04 | 75 | 51 | 3 | int:IGFL3 | |
| Interaction | ZNF708 interactions | 9.36e-04 | 18 | 51 | 2 | int:ZNF708 | |
| Interaction | COL13A1 interactions | 9.36e-04 | 18 | 51 | 2 | int:COL13A1 | |
| Interaction | ZNF358 interactions | 1.04e-03 | 19 | 51 | 2 | int:ZNF358 | |
| Interaction | DCANP1 interactions | 1.04e-03 | 19 | 51 | 2 | int:DCANP1 | |
| Interaction | TDRD1 interactions | 1.04e-03 | 19 | 51 | 2 | int:TDRD1 | |
| Interaction | FRAT1 interactions | 1.04e-03 | 19 | 51 | 2 | int:FRAT1 | |
| Interaction | ZNF707 interactions | 1.05e-03 | 79 | 51 | 3 | int:ZNF707 | |
| Interaction | CCL3 interactions | 1.06e-03 | 178 | 51 | 4 | int:CCL3 | |
| Interaction | ZNF791 interactions | 1.16e-03 | 20 | 51 | 2 | int:ZNF791 | |
| Interaction | DEFB125 interactions | 1.16e-03 | 20 | 51 | 2 | int:DEFB125 | |
| Cytoband | 17q21.33 | 9.65e-04 | 41 | 51 | 2 | 17q21.33 | |
| GeneFamily | Laminin subunits | 2.12e-11 | 12 | 37 | 5 | 626 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 3.15e-08 | 4 | 37 | 3 | 628 | |
| GeneFamily | Argonaute/PIWI family | 1.13e-04 | 8 | 37 | 2 | 408 | |
| GeneFamily | Cadherin related | 5.44e-04 | 17 | 37 | 2 | 24 | |
| GeneFamily | WAP four-disulfide core domain containing|Fibronectin type III domain containing | 6.11e-04 | 18 | 37 | 2 | 361 | |
| GeneFamily | CD molecules|Mucins | 8.35e-04 | 21 | 37 | 2 | 648 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.31e-03 | 161 | 37 | 3 | 593 | |
| GeneFamily | PHD finger proteins | 1.46e-02 | 90 | 37 | 2 | 88 | |
| Coexpression | NABA_MATRISOME | AMBP HSPG2 LAMB4 INHBE FBN2 MEGF6 ADAMTS3 WFIKKN1 WFIKKN2 SLIT1 FGA LAMA3 LAMA4 LAMC1 NID1 LAMC3 LTBP1 LTBP2 MUC13 USH2A LTBP4 MUC5AC MEGF11 FBN3 | 1.08e-20 | 1026 | 51 | 24 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | LAMB4 FBN2 SLIT1 FGA LAMA3 LAMA4 LAMC1 NID1 LAMC3 LTBP1 LTBP2 USH2A LTBP4 FBN3 | 1.08e-18 | 196 | 51 | 14 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | HSPG2 LAMB4 FBN2 SLIT1 FGA LAMA3 LAMA4 LAMC1 NID1 LAMC3 LTBP1 LTBP2 USH2A LTBP4 FBN3 | 3.19e-18 | 275 | 51 | 15 | M5884 |
| Coexpression | NABA_MATRISOME | AMBP HSPG2 INHBE FBN2 MEGF6 ADAMTS3 WFIKKN1 WFIKKN2 SLIT1 FGA LAMA3 LAMA4 LAMC1 NID1 LAMC3 LTBP1 LTBP2 MUC13 LTBP4 MUC5AC MEGF11 | 6.01e-17 | 1008 | 51 | 21 | MM17056 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 8.47e-15 | 40 | 51 | 8 | M5887 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | FBN2 SLIT1 FGA LAMA3 LAMA4 LAMC1 NID1 LAMC3 LTBP1 LTBP2 LTBP4 | 8.50e-14 | 191 | 51 | 11 | MM17059 |
| Coexpression | NABA_CORE_MATRISOME | HSPG2 FBN2 SLIT1 FGA LAMA3 LAMA4 LAMC1 NID1 LAMC3 LTBP1 LTBP2 LTBP4 | 1.24e-13 | 270 | 51 | 12 | MM17057 |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 6.02e-08 | 20 | 51 | 4 | MM17053 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 1.06e-07 | 117 | 51 | 6 | M39300 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 1.10e-07 | 23 | 51 | 4 | M48001 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 6.37e-07 | 35 | 51 | 4 | MM17054 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_GRIA2_POS_ARTERIAL_ENDO_CELL | 2.98e-06 | 115 | 51 | 5 | M45752 | |
| Coexpression | VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 | 3.74e-06 | 54 | 51 | 4 | M4737 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 5.87e-06 | 681 | 51 | 9 | M39175 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C1 | 6.58e-06 | 19 | 51 | 3 | M16026 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 9.27e-06 | 385 | 51 | 7 | M39264 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | AMBP INHBE MEGF6 ADAMTS3 WFIKKN1 WFIKKN2 MUC13 MUC5AC MEGF11 | 1.12e-05 | 738 | 51 | 9 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | AMBP INHBE MEGF6 ADAMTS3 WFIKKN1 WFIKKN2 MUC13 MUC5AC MEGF11 | 1.28e-05 | 751 | 51 | 9 | M5885 |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | AMBP FAT1 TFPI2 GNPTAB SLC44A2 FGA LAMA3 LAMC1 MUC13 SLC4A4 NOTCH2 | 2.75e-05 | 1276 | 51 | 11 | M39173 |
| Coexpression | GSE360_CTRL_VS_L_MAJOR_DC_UP | 4.24e-05 | 199 | 51 | 5 | M5145 | |
| Coexpression | GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_UP | 4.24e-05 | 199 | 51 | 5 | M7710 | |
| Coexpression | GSE3982_MAST_CELL_VS_TH1_UP | 4.24e-05 | 199 | 51 | 5 | M5453 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 4.35e-05 | 200 | 51 | 5 | M5930 | |
| Coexpression | PILON_KLF1_TARGETS_UP | 5.13e-05 | 503 | 51 | 7 | M2226 | |
| Coexpression | TRAVAGLINI_LUNG_LYMPHATIC_CELL | 5.36e-05 | 209 | 51 | 5 | M41670 | |
| Coexpression | CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP | 6.04e-05 | 39 | 51 | 3 | M13339 | |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TCONV_CD4_TCELL_DN | 6.30e-05 | 110 | 51 | 4 | M8946 | |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_DN | 7.59e-05 | 225 | 51 | 5 | M6175 | |
| Coexpression | PILON_KLF1_TARGETS_UP | 8.10e-05 | 541 | 51 | 7 | MM1061 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP | 9.13e-05 | 121 | 51 | 4 | M12828 | |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_DN | 1.01e-04 | 239 | 51 | 5 | MM1274 | |
| Coexpression | CHICAS_RB1_TARGETS_CONFLUENT | 1.08e-04 | 567 | 51 | 7 | M2129 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP | 1.28e-04 | 132 | 51 | 4 | MM465 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | 1.54e-04 | 600 | 51 | 7 | M39055 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN | 1.60e-04 | 54 | 51 | 3 | M5312 | |
| Coexpression | DESCARTES_FETAL_LIVER_VASCULAR_ENDOTHELIAL_CELLS | 1.79e-04 | 144 | 51 | 4 | M40230 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN | 1.89e-04 | 57 | 51 | 3 | MM463 | |
| Coexpression | NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP | 2.25e-04 | 284 | 51 | 5 | M16975 | |
| Coexpression | POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN | 2.31e-04 | 61 | 51 | 3 | M8510 | |
| Coexpression | PKCA_DN.V1_DN | 2.31e-04 | 154 | 51 | 4 | M2754 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_BRAIN_LIVER_LUNG_METASTASTASES | 2.86e-04 | 13 | 51 | 2 | M48004 | |
| Coexpression | CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN | 3.37e-04 | 170 | 51 | 4 | M8689 | |
| Coexpression | SESTO_RESPONSE_TO_UV_C8 | 3.61e-04 | 71 | 51 | 3 | M2948 | |
| Coexpression | HEVNER_TELENCEPHALON_VASCULAR_ENDOTHELIUM_AND_MENINGEAL_CELLS | 3.83e-04 | 15 | 51 | 2 | MM402 | |
| Coexpression | LINDVALL_IMMORTALIZED_BY_TERT_DN | 3.92e-04 | 73 | 51 | 3 | M1561 | |
| Coexpression | CYCLIN_D1_UP.V1_UP | 4.82e-04 | 187 | 51 | 4 | M2654 | |
| Coexpression | DESCARTES_FETAL_SPLEEN_AFP_ALB_POSITIVE_CELLS | 4.92e-04 | 188 | 51 | 4 | M40287 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 4.95e-04 | 17 | 51 | 2 | M47995 | |
| Coexpression | NABA_SECRETED_FACTORS | 5.00e-04 | 338 | 51 | 5 | MM17064 | |
| Coexpression | NABA_SECRETED_FACTORS | 5.34e-04 | 343 | 51 | 5 | M5883 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 5.54e-04 | 194 | 51 | 4 | M39122 | |
| Coexpression | GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_DN | 6.09e-04 | 199 | 51 | 4 | M9398 | |
| Coexpression | GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN | 6.09e-04 | 199 | 51 | 4 | M3479 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_6H_BMDC_UP | 6.09e-04 | 199 | 51 | 4 | M3918 | |
| Coexpression | GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_TREATED_DN | 6.09e-04 | 199 | 51 | 4 | M7443 | |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_MGP_HIGH_FIBROBLASTS | 6.13e-04 | 85 | 51 | 3 | M43623 | |
| Coexpression | GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_UP | 6.21e-04 | 200 | 51 | 4 | M6371 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 6.75e-04 | 767 | 51 | 7 | M39209 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | 7.08e-04 | 365 | 51 | 5 | M39018 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP | 7.59e-04 | 211 | 51 | 4 | M12225 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_DN | 7.86e-04 | 213 | 51 | 4 | M12176 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | 8.10e-04 | 1035 | 51 | 8 | M9898 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 1.19e-07 | 97 | 51 | 6 | GSM777043_100 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 4.84e-07 | 65 | 51 | 5 | gudmap_kidney_P3_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 1.00e-06 | 445 | 51 | 9 | GSM777043_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | 1.23e-06 | 456 | 51 | 9 | GSM777032_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | 1.30e-06 | 459 | 51 | 9 | GSM777037_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 8.85e-06 | 437 | 51 | 8 | GSM777046_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 9.15e-06 | 439 | 51 | 8 | GSM777059_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 1.10e-05 | 450 | 51 | 8 | GSM777063_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 1.41e-05 | 466 | 51 | 8 | GSM777050_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 2.16e-05 | 356 | 51 | 7 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | BM Top 100 - ovary | 2.41e-05 | 70 | 51 | 4 | BM Top 100 - ovary | |
| CoexpressionAtlas | BM Top 100 - adipose tissue omental | 3.00e-05 | 74 | 51 | 4 | BM Top 100 - adipose tissue omental | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 4.83e-05 | 166 | 51 | 5 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 6.76e-05 | 91 | 51 | 4 | GSM777059_100 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.01e-05 | 293 | 51 | 6 | gudmap_developingGonad_e18.5_testes_1000_k4 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | 8.27e-05 | 773 | 51 | 9 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 | |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 8.33e-05 | 96 | 51 | 4 | GSM777063_100 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 9.88e-05 | 453 | 51 | 7 | GSM777067_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 1.02e-04 | 455 | 51 | 7 | GSM777055_500 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 1.22e-04 | 202 | 51 | 5 | gudmap_kidney_P2_CapMes_Crym_k3_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | 1.64e-04 | 846 | 51 | 9 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_1000 | |
| CoexpressionAtlas | placenta | 1.82e-04 | 349 | 51 | 6 | placenta | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.97e-04 | 120 | 51 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.84e-04 | 379 | 51 | 6 | gudmap_developingLowerUrinaryTract_P1_bladder_B_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_100 | 3.07e-04 | 11 | 51 | 2 | gudmap_developingGonad_e18.5_epididymis_100_k5 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | 3.69e-04 | 398 | 51 | 6 | gudmap_kidney_P4_CapMesRenVes_Crym_500 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.84e-04 | 401 | 51 | 6 | gudmap_kidney_P1_CapMes_Crym_k1_1000 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | 3.90e-04 | 951 | 51 | 9 | Arv_EB-LF_2500_K2 | |
| CoexpressionAtlas | MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 4.27e-04 | 761 | 51 | 8 | PCBC_ratio_MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.29e-04 | 265 | 51 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 4.39e-04 | 148 | 51 | 4 | gudmap_kidney_P3_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | 4.53e-04 | 768 | 51 | 8 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_500 | 4.54e-04 | 414 | 51 | 6 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_500 | |
| CoexpressionAtlas | MESO-5 amniotic fluid MSC_vs_MESO-5 blastocyst-Confounder_removed-fold2.0_adjp0.05 | 4.78e-04 | 418 | 51 | 6 | PCBC_ratio_MESO-5 amniotic fluid MSC_vs_MESO-5 blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 5.60e-04 | 793 | 51 | 8 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | FBN2 MEGF6 WFIKKN1 SLC44A2 NID1 LTBP1 DLK1 LTBP2 LTBP4 FBN3 NOTCH2 | 5.97e-04 | 1466 | 51 | 11 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | 6.24e-04 | 806 | 51 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_500 | 6.55e-04 | 291 | 51 | 5 | gudmap_kidney_P2_CapMes_Crym_500 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MaxArch_2500_K1 | 6.65e-04 | 71 | 51 | 3 | facebase_RNAseq_e9.5_MaxArch_2500_K1 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.76e-04 | 293 | 51 | 5 | gudmap_kidney_P0_JuxtaGlom_Ren1_k3_1000 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_1000 | 7.50e-04 | 633 | 51 | 7 | gudmap_kidney_P1_CapMes_Crym_1000 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_1000 | 7.71e-04 | 636 | 51 | 7 | gudmap_kidney_P2_CapMes_Crym_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_200 | 8.24e-04 | 175 | 51 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_200 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#1_top-relative-expression-ranked_200 | 9.42e-04 | 19 | 51 | 2 | gudmap_developingGonad_e18.5_epididymis_200_k1 | |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.16e-03 | 1108 | 51 | 9 | Arv_SC_fibroblast_2500_K2 | |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.20e-03 | 1113 | 51 | 9 | Arv_SC-HD_2500_K2 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.85e-11 | 195 | 51 | 8 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 6.10e-11 | 196 | 51 | 8 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 6.35e-11 | 197 | 51 | 8 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 7.16e-11 | 200 | 51 | 8 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | -Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.10e-09 | 173 | 51 | 7 | 88be9182fbb1bc83531cd41e59ea57c112a21d54 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-09 | 181 | 51 | 7 | 6d1f1ad35778a2a227f966f11f6edd8e89452576 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.97e-09 | 188 | 51 | 7 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-09 | 193 | 51 | 7 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-09 | 193 | 51 | 7 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-09 | 193 | 51 | 7 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.63e-09 | 196 | 51 | 7 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.63e-09 | 196 | 51 | 7 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.63e-09 | 196 | 51 | 7 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.73e-09 | 197 | 51 | 7 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-09 | 197 | 51 | 7 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-09 | 197 | 51 | 7 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-09 | 197 | 51 | 7 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 | |
| ToppCell | COPD-Stromal|COPD / Disease state, Lineage and Cell class | 2.73e-09 | 197 | 51 | 7 | d5390d86acaa8c39f1da893e8d2271f9ed2951d7 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.82e-09 | 198 | 51 | 7 | 75d104eead681f6bf47c4dd24913cc768c9a1717 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.82e-09 | 198 | 51 | 7 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | IPF-Stromal|IPF / Disease state, Lineage and Cell class | 2.82e-09 | 198 | 51 | 7 | ece914c32c9b123b779aa9624b92e6230763a20e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.82e-09 | 198 | 51 | 7 | aae663c6da70b6e716edeed50cc7d3962d78e697 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.93e-09 | 199 | 51 | 7 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.93e-09 | 199 | 51 | 7 | 0019cfaa586a450c2e4952d1184a540561c8d0ba | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.93e-09 | 199 | 51 | 7 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.03e-09 | 200 | 51 | 7 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.03e-09 | 200 | 51 | 7 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | cellseq-Mesenchymal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.03e-09 | 200 | 51 | 7 | 238285fc372ce2e5e4341fc3084a3a833bf4a0a6 | |
| ToppCell | Bronchial-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-09 | 200 | 51 | 7 | 5ea12e17f50fefbf5534e487af3392b2fa2d13ad | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-09 | 200 | 51 | 7 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.03e-09 | 200 | 51 | 7 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.03e-09 | 200 | 51 | 7 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-09 | 200 | 51 | 7 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-09 | 200 | 51 | 7 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-09 | 200 | 51 | 7 | b04831708fa20471a127b87e8db3728b6e729ce8 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-09 | 200 | 51 | 7 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-09 | 200 | 51 | 7 | 6316c288022719b9e6c4332c5cb9041e1188d0e8 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 3.03e-09 | 200 | 51 | 7 | c2c6f687c49ba790174b27c7b8b084af30b34c86 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.02e-08 | 169 | 51 | 6 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.02e-08 | 169 | 51 | 6 | 6ff1172da690ca17f7108f1617b255b766971a57 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.05e-08 | 181 | 51 | 6 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.05e-08 | 181 | 51 | 6 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.25e-08 | 182 | 51 | 6 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.25e-08 | 182 | 51 | 6 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.45e-08 | 183 | 51 | 6 | 07ca2786e62eca9feecf5e54a11864a960f7641a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.66e-08 | 184 | 51 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.66e-08 | 184 | 51 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.66e-08 | 184 | 51 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL14A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 6.88e-08 | 185 | 51 | 6 | 506eee2c1b6e8acec3aa8b2c66868010006c4c14 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.88e-08 | 185 | 51 | 6 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 7.33e-08 | 187 | 51 | 6 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | -Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 7.57e-08 | 188 | 51 | 6 | 038f48e8daaeb72716e975d22a6b004a90654960 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.81e-08 | 189 | 51 | 6 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | moderate-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.81e-08 | 189 | 51 | 6 | 22a19365782003c18ec8dddcdbfdaa82c4e330f6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.81e-08 | 189 | 51 | 6 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.06e-08 | 190 | 51 | 6 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.06e-08 | 190 | 51 | 6 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.06e-08 | 190 | 51 | 6 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.06e-08 | 190 | 51 | 6 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.06e-08 | 190 | 51 | 6 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.31e-08 | 191 | 51 | 6 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.31e-08 | 191 | 51 | 6 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.31e-08 | 191 | 51 | 6 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.31e-08 | 191 | 51 | 6 | 4e4488380379ed29d7898bae4e24221e7c67eb9d | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.31e-08 | 191 | 51 | 6 | b9ae5af426e7a1f2652a47700bb168371bd2dec6 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.31e-08 | 191 | 51 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.57e-08 | 192 | 51 | 6 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.57e-08 | 192 | 51 | 6 | ad48c941a3ddfd9a5146bafc2209da577bb50531 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.57e-08 | 192 | 51 | 6 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.57e-08 | 192 | 51 | 6 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.57e-08 | 192 | 51 | 6 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.57e-08 | 192 | 51 | 6 | 7b48df661f61ce494bf6f0b9a74b0422e29c24bf | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.57e-08 | 192 | 51 | 6 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.57e-08 | 192 | 51 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.57e-08 | 192 | 51 | 6 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.57e-08 | 192 | 51 | 6 | 19b94f254d51b9bda3d9b7c6f85e27ecb58409c8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.84e-08 | 193 | 51 | 6 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.84e-08 | 193 | 51 | 6 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.84e-08 | 193 | 51 | 6 | 68089ba4123e2f9bea9aae0023a844b5a57bfc0e | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.11e-08 | 194 | 51 | 6 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.11e-08 | 194 | 51 | 6 | 02b8102be9414d6964cd71019613edff6d88b893 | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 9.11e-08 | 194 | 51 | 6 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 9.40e-08 | 195 | 51 | 6 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.40e-08 | 195 | 51 | 6 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.40e-08 | 195 | 51 | 6 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.40e-08 | 195 | 51 | 6 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.40e-08 | 195 | 51 | 6 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.40e-08 | 195 | 51 | 6 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.40e-08 | 195 | 51 | 6 | 4658fb197657d7692ee344ae76b11b0210c418ba | |
| ToppCell | COVID-19-Heart-Low_count_Fib|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.40e-08 | 195 | 51 | 6 | e09590d1f51d5fa57fceb84c9f48f84b23d4d224 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 9.40e-08 | 195 | 51 | 6 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.40e-08 | 195 | 51 | 6 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.40e-08 | 195 | 51 | 6 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.40e-08 | 195 | 51 | 6 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.40e-08 | 195 | 51 | 6 | 79a6e8e6de040ff07539e8901fc407363a50e355 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.40e-08 | 195 | 51 | 6 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.40e-08 | 195 | 51 | 6 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.40e-08 | 195 | 51 | 6 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.40e-08 | 195 | 51 | 6 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.40e-08 | 195 | 51 | 6 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| Computational | Metal / Ca ion binding. | 5.61e-05 | 133 | 34 | 5 | MODULE_324 | |
| Computational | Adhesion molecules. | 7.41e-05 | 141 | 34 | 5 | MODULE_122 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.12e-04 | 50 | 34 | 3 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_1 | |
| Computational | Heart, liver, kidney and pancreas metabolic and xenobiotic response genes. | 8.78e-04 | 835 | 34 | 9 | MODULE_88 | |
| Computational | Ovary genes. | 9.22e-04 | 368 | 34 | 6 | MODULE_1 | |
| Computational | DRG (dorsal root ganglia) genes. | 1.15e-03 | 384 | 34 | 6 | MODULE_2 | |
| Computational | Intermediate filaments. | 1.67e-03 | 75 | 34 | 3 | MODULE_154 | |
| Computational | Intermediate filaments and keratins. | 2.01e-03 | 80 | 34 | 3 | MODULE_357 | |
| Computational | Genes in the cancer module 297. | 2.01e-03 | 80 | 34 | 3 | MODULE_297 | |
| Drug | AC1L1G72 | 2.11e-11 | 11 | 51 | 5 | CID000003553 | |
| Drug | kalinin | 3.45e-11 | 55 | 51 | 7 | CID000032518 | |
| Drug | Rgd Peptide | 1.18e-10 | 239 | 51 | 10 | CID000104802 | |
| Drug | AC1L1B58 | 5.26e-09 | 29 | 51 | 5 | CID000001288 | |
| Drug | Calcort | 2.19e-08 | 38 | 51 | 5 | CID000026709 | |
| Drug | YIGSR | 2.29e-08 | 79 | 51 | 6 | CID000123977 | |
| Drug | 1,2-dimethylhydrazine | 3.82e-08 | 86 | 51 | 6 | CID000001322 | |
| Drug | CC270 | 2.11e-07 | 59 | 51 | 5 | CID006918852 | |
| Drug | AC1L9INI | 2.11e-07 | 59 | 51 | 5 | CID000445839 | |
| Drug | LG 5 | 2.29e-07 | 60 | 51 | 5 | CID011840957 | |
| Drug | dysprosium | 6.61e-07 | 74 | 51 | 5 | CID000023912 | |
| Drug | 2-amino-5-methylpyridine | 8.07e-07 | 77 | 51 | 5 | CID000015348 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 1.17e-06 | 83 | 51 | 5 | CID011968896 | |
| Drug | I-Q-S | 1.31e-06 | 156 | 51 | 6 | CID000003540 | |
| Drug | NSC 714187 | 1.32e-06 | 85 | 51 | 5 | CID005288693 | |
| Drug | Ikvav | 1.56e-06 | 38 | 51 | 4 | CID000131343 | |
| Drug | BM165 | 1.73e-06 | 11 | 51 | 3 | CID003352881 | |
| Drug | H-9 dihydrochloride | 1.76e-06 | 90 | 51 | 5 | CID000003544 | |
| Drug | AC1O0B8G | 1.85e-06 | 262 | 51 | 7 | CID000091605 | |
| Drug | hyaluronan | 1.90e-06 | 263 | 51 | 7 | CID000024759 | |
| Drug | chondroitin sulfate | 3.53e-06 | 413 | 51 | 8 | CID000024766 | |
| Drug | Rgds Peptide | 3.94e-06 | 106 | 51 | 5 | CID000107775 | |
| Drug | funiferine N-oxide | 4.39e-06 | 49 | 51 | 4 | CID000191631 | |
| Drug | Gdrgdsp | 4.52e-06 | 109 | 51 | 5 | CID000115346 | |
| Drug | AC1L1C2F | 4.73e-06 | 110 | 51 | 5 | CID000001711 | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Up 200; 8uM; MCF7; HT_HG-U133A | 4.92e-06 | 196 | 51 | 6 | 3604_UP | |
| Drug | 3-Acetylcoumarin [3949-36-8]; Up 200; 21.2uM; MCF7; HT_HG-U133A | 5.06e-06 | 197 | 51 | 6 | 3382_UP | |
| Drug | Iproniazide phosphate [305-33-9]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 5.21e-06 | 198 | 51 | 6 | 2288_UP | |
| Drug | Etidronic acid, disodium salt [7414-83-7]; Up 200; 16uM; MCF7; HT_HG-U133A | 5.52e-06 | 200 | 51 | 6 | 4387_UP | |
| Drug | B-Ms | 5.63e-06 | 114 | 51 | 5 | CID000445091 | |
| Drug | pyrachlostrobin | 1.06e-05 | 811 | 51 | 10 | ctd:C513428 | |
| Drug | ALT-711 | 1.37e-05 | 21 | 51 | 3 | CID000216304 | |
| Drug | Vitallium | 1.71e-05 | 244 | 51 | 6 | ctd:D014800 | |
| Drug | Sikvav | 2.07e-05 | 24 | 51 | 3 | CID005487517 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 2.50e-05 | 155 | 51 | 5 | 6817_DN | |
| Drug | Betamethasone-d5 | LAMB4 INHBE FGA LAMA3 LAMA4 LAMC1 LAMC3 LTBP1 DLK1 ABCG2 MUC5AC FBN3 | 3.06e-05 | 1340 | 51 | 12 | CID000003003 |
| Drug | Grgds | 3.60e-05 | 83 | 51 | 4 | CID000123811 | |
| Drug | AC1NAG0I | 5.02e-05 | 32 | 51 | 3 | CID004476319 | |
| Drug | tranylcypromine | 5.17e-05 | 91 | 51 | 4 | CID000005530 | |
| Drug | GW 4064 | 5.18e-05 | 438 | 51 | 7 | ctd:C412815 | |
| Drug | Loperamide hydrochloride [34552-83-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 5.97e-05 | 186 | 51 | 5 | 1533_UP | |
| Drug | Althiazide [5588-16-9]; Up 200; 10.4uM; HL60; HT_HG-U133A | 7.29e-05 | 194 | 51 | 5 | 2527_UP | |
| Drug | Verteporfin [129497-78-5]; Up 200; 2.8uM; MCF7; HT_HG-U133A | 7.29e-05 | 194 | 51 | 5 | 3556_UP | |
| Drug | Urapidil hydrochloride [64887-14-5]; Up 200; 9.4uM; HL60; HT_HG-U133A | 7.47e-05 | 195 | 51 | 5 | 3078_UP | |
| Drug | Ganciclovir [82410-32-0]; Up 200; 15.6uM; MCF7; HT_HG-U133A | 7.65e-05 | 196 | 51 | 5 | 3368_UP | |
| Drug | AC1L3XKP | 7.80e-05 | 37 | 51 | 3 | CID000123931 | |
| Drug | Sulmazole [73384-60-8]; Up 200; 14uM; PC3; HT_HG-U133A | 7.84e-05 | 197 | 51 | 5 | 4009_UP | |
| Drug | Nifuroxazide [965-52-6]; Up 200; 14.6uM; PC3; HT_HG-U133A | 8.03e-05 | 198 | 51 | 5 | 4253_UP | |
| Drug | GSK-3 Inhibitor IX; Down 200; 0.5uM; PC3; HT_HG-U133A | 8.03e-05 | 198 | 51 | 5 | 6559_DN | |
| Drug | Ticlopidine hydrochloride [53885-35-1]; Up 200; 13.4uM; PC3; HG-U133A | 8.03e-05 | 198 | 51 | 5 | 1895_UP | |
| Drug | Epirizole [18694-40-1]; Up 200; 17uM; MCF7; HT_HG-U133A | 8.22e-05 | 199 | 51 | 5 | 5995_UP | |
| Drug | Bendroflumethiazide [73-48-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 8.22e-05 | 199 | 51 | 5 | 3934_UP | |
| Drug | ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A | 8.22e-05 | 199 | 51 | 5 | 5931_UP | |
| Drug | Benzylpenicillin sodium [69-57-8]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 8.42e-05 | 200 | 51 | 5 | 6839_UP | |
| Drug | AC1L1EIK | 9.87e-05 | 40 | 51 | 3 | CID000002807 | |
| Drug | LMWH | 1.04e-04 | 663 | 51 | 8 | CID000000772 | |
| Drug | sulfate | AMBP HSPG2 LAMB4 ADAMTS3 LAMA3 LAMA4 LAMC1 NID1 LAMC3 ABCG2 MUC5AC | 1.10e-04 | 1292 | 51 | 11 | CID000001117 |
| Drug | quinaprilat | 1.23e-04 | 43 | 51 | 3 | CID000107994 | |
| Drug | CS-0398 | 1.31e-04 | 44 | 51 | 3 | CID005288149 | |
| Drug | dermatan sulfate | 1.32e-04 | 220 | 51 | 5 | CID000032756 | |
| Drug | rhamnose | 1.39e-04 | 356 | 51 | 6 | CID000000840 | |
| Drug | colchine | 2.07e-04 | 383 | 51 | 6 | CID000002833 | |
| Drug | maltos | 2.38e-04 | 393 | 51 | 6 | CID000000294 | |
| Drug | 2,4-diaminopyrimidine | 2.42e-04 | 54 | 51 | 3 | CID000067431 | |
| Drug | 1xqc | 2.67e-04 | 11 | 51 | 2 | CID005287617 | |
| Drug | trypanothione disulfide | 2.73e-04 | 140 | 51 | 4 | CID000115098 | |
| Drug | butyrate | 2.82e-04 | 767 | 51 | 8 | CID000000264 | |
| Disease | connective tissue disease (implicated_via_orthology) | 8.10e-06 | 3 | 49 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | Hennekam syndrome (is_implicated_in) | 8.10e-06 | 3 | 49 | 2 | DOID:0060366 (is_implicated_in) | |
| Disease | Hennekam lymphangiectasia-lymphedema syndrome | 8.10e-06 | 3 | 49 | 2 | C0340834 | |
| Disease | Liver Cirrhosis, Experimental | 3.77e-05 | 774 | 49 | 8 | C0023893 | |
| Disease | cholesteryl ester 16:2 measurement | 5.64e-05 | 7 | 49 | 2 | EFO_0021435 | |
| Disease | birth weight, pelvic organ prolapse | 7.51e-05 | 49 | 49 | 3 | EFO_0004344, EFO_0004710 | |
| Disease | body surface area | 8.77e-05 | 643 | 49 | 7 | EFO_0022196 | |
| Disease | Glaucoma | 9.65e-05 | 9 | 49 | 2 | C0017601 | |
| Disease | Marfan Syndrome | 1.47e-04 | 11 | 49 | 2 | C0024796 | |
| Disease | body weight | 2.03e-04 | 1261 | 49 | 9 | EFO_0004338 | |
| Disease | caffeine measurement | 2.80e-04 | 15 | 49 | 2 | EFO_0021177 | |
| Disease | Glioblastoma | 3.11e-04 | 79 | 49 | 3 | C0017636 | |
| Disease | systemic lupus erythematosus | 3.32e-04 | 799 | 49 | 7 | MONDO_0007915 | |
| Disease | Hodgkins lymphoma | 3.48e-04 | 82 | 49 | 3 | EFO_0000183 | |
| Disease | alcoholic liver disease | 3.48e-04 | 82 | 49 | 3 | EFO_0008573 | |
| Disease | Giant Cell Glioblastoma | 3.73e-04 | 84 | 49 | 3 | C0334588 | |
| Disease | Drug toxicity | 3.73e-04 | 84 | 49 | 3 | C0013221 | |
| Disease | Adverse reaction to drug | 3.73e-04 | 84 | 49 | 3 | C0041755 | |
| Disease | bipolar disorder, sex interaction measurement | 4.06e-04 | 18 | 49 | 2 | EFO_0008343, MONDO_0004985 | |
| Disease | Squamous cell carcinoma of esophagus | 5.35e-04 | 95 | 49 | 3 | C0279626 | |
| Disease | blood cobalt measurement | 6.40e-04 | 101 | 49 | 3 | EFO_0007577 | |
| Disease | C-X-C motif chemokine 10 measurement | 7.98e-04 | 109 | 49 | 3 | EFO_0008056 | |
| Disease | Glioblastoma Multiforme | 8.42e-04 | 111 | 49 | 3 | C1621958 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 9.23e-04 | 27 | 49 | 2 | DOID:10584 (implicated_via_orthology) | |
| Disease | lung small cell carcinoma (is_implicated_in) | 9.93e-04 | 28 | 49 | 2 | DOID:5409 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | 1.04e-03 | 702 | 49 | 6 | C0009402 | |
| Disease | level of Sphingomyelin (d42:2) in blood serum | 1.07e-03 | 29 | 49 | 2 | OBA_2045183 | |
| Disease | pulmonary tuberculosis | 1.07e-03 | 29 | 49 | 2 | EFO_1000049 | |
| Disease | level of Sphingomyelin (d38:1) in blood serum | 1.14e-03 | 30 | 49 | 2 | OBA_2045180 | |
| Disease | Ischemic stroke, von Willebrand factor measurement | 1.14e-03 | 30 | 49 | 2 | EFO_0004629, HP_0002140 | |
| Disease | Colorectal Neoplasms | 1.16e-03 | 277 | 49 | 4 | C0009404 | |
| Disease | level of Sphingomyelin (d40:1) in blood serum | 1.30e-03 | 32 | 49 | 2 | OBA_2045182 | |
| Disease | factor VIII measurement, venous thromboembolism | 1.46e-03 | 34 | 49 | 2 | EFO_0004286, EFO_0004630 | |
| Disease | acute lymphoblastic leukemia (is_marker_for) | 1.46e-03 | 34 | 49 | 2 | DOID:9952 (is_marker_for) | |
| Disease | reticulocyte count | 1.61e-03 | 1045 | 49 | 7 | EFO_0007986 | |
| Disease | multiple myeloma (is_marker_for) | 1.64e-03 | 36 | 49 | 2 | DOID:9538 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KCVLFPYGGCQGNGN | 311 | P02760 | |
| GAACQGPQDEYRQCG | 556 | O14514 | |
| NGAICQNFPGSFNCV | 3911 | Q6V0I7 | |
| FCPGLNATGNNPCNY | 591 | Q9UNQ0 | |
| IQGQPCFCKYAQGAD | 486 | Q9H9G7 | |
| DLCDNGQCLNAPGGY | 1371 | Q75N90 | |
| VCPAEYLQVNGGNNC | 1631 | Q75N90 | |
| GCQNQLGGYRCSCPQ | 2541 | Q75N90 | |
| TYGAECFPACNPQNG | 21 | P80370 | |
| QGQPCFCKYAQGADS | 486 | Q9UKV8 | |
| TGQYCEQCGPGYVGN | 1646 | P98160 | |
| NGGFVCQCRGLYTGQ | 4071 | Q14517 | |
| QCQCPQGFTGQYCDS | 206 | Q04721 | |
| VNGYQCNCQPGTSGV | 626 | Q04721 | |
| NQVCAGGYFGQDCAQ | 651 | A6BM72 | |
| QRCAPGTFGYGCQQL | 781 | A6BM72 | |
| QGIYAGGGVCINCQH | 381 | Q16787 | |
| SNYFGCQGCQCDIGG | 676 | Q16787 | |
| GGGINSVSYCNQGCA | 496 | Q3T906 | |
| GSSCQNPGCDAVYQG | 146 | Q9UKP3 | |
| VIPNNYCDFCLGGSN | 256 | Q92784 | |
| LQPEGYQLNYCSGQC | 266 | P58166 | |
| CYQGFQAPQDGQGCV | 1271 | Q14766 | |
| PQGHNYCSVNNGGCT | 1206 | P14543 | |
| PVGFEYQEQSGQCCG | 5431 | P98088 | |
| GGQDCPGVNFEYQLC | 586 | O15072 | |
| QVCGLCGNYNGDPAD | 606 | Q9Y6R7 | |
| GFLYNGQACVPIQQC | 1571 | Q9Y6R7 | |
| GSLCGLCGNYNQDPA | 3406 | Q9Y6R7 | |
| QGGQGVCLPNYEATC | 4061 | Q9Y6R7 | |
| GQYGGQPCVGNAFET | 56 | P10643 | |
| GSYQCLCPQGFQLAN | 1156 | Q14767 | |
| NCQAANLNGIYYPGG | 811 | P02671 | |
| QNLPGSFQCLCDQGY | 1066 | Q8N2S1 | |
| GGAYSNVCSPKNGQC | 511 | A4D0S4 | |
| VTGQDCGACDPGFYN | 911 | P11047 | |
| CGACDPGFYNLQSGQ | 916 | P11047 | |
| PGFYNLQSGQGCERC | 921 | P11047 | |
| QCPNARCQFAFYGGE | 421 | Q8IWA5 | |
| QAYCLGCGQPQDEGD | 596 | Q5T1A1 | |
| IGTYCGQPVCENGCQ | 171 | P35556 | |
| PCQNGAVCQDGIDGY | 156 | P82279 | |
| CQNGGTCENLPGNYT | 406 | P82279 | |
| APCGQAAYGQFGQGD | 76 | P53992 | |
| GAVRCICNENYAGPN | 151 | Q16363 | |
| QGHFGPGCEQRCQCQ | 906 | O75095 | |
| CNQCQPGFYISPGNA | 931 | O75445 | |
| NGQYVACGSNCGVVN | 436 | Q9Y5J1 | |
| TYFNPCLAGCVNSGN | 576 | Q9H2Y9 | |
| CVPGYQEDANGNCQK | 391 | Q9H3R2 | |
| TNQQQCYCYCGGPGE | 191 | Q5T6S3 | |
| QGSQCQFCSDPNKYG | 771 | Q8WWQ8 | |
| NQAACNCLPAYTGDG | 1536 | Q8WWQ8 | |
| RGGVNPFTNGCCNNV | 226 | Q9C0B5 | |
| LQQCHPFVYGGCEGN | 381 | Q96NZ8 | |
| QGVHTGNNPYQCGEC | 361 | P17031 | |
| GNNPYQCGECGKAFG | 366 | P17031 | |
| KYGGNLVGNNCNFVP | 676 | Q9Y6R1 | |
| CRQFLYGGCEGNANN | 61 | P48307 | |
| NGGVCVDGVGNYTCQ | 1016 | O75093 | |
| PQNSTYCVQCTGDGG | 236 | Q9HD43 | |
| CQSFVYGGCEGNGNN | 411 | Q8TEU8 | |
| VCFQPNSGAQGEYAG | 611 | P23378 | |
| YGNPFAGQADDCQPC | 741 | Q9Y6N6 |